Skip to main content
. 2023 May 30;42(9):774–780. doi: 10.1097/INF.0000000000003981

TABLE 2.

Summary of Coinfection with SARS-CoV-2 by Pathogen (N = 19,199)

Number of Participants With Pathogen SARS-CoV-2 Positive, N = 1466 SARS-CoV-2 Negative, N = 17,733 P *
Rhino/enterovirus 6285 230 (15.69%) 6055 (34.15%) <0.001
RSV 2473 45 (3.07%) 2428 (13.69%) <0.001
Influenza A 193 5 (0.34%) 188 (1.06%) 0.008
Influenza B 6 2 (0.14%) 4 (0.02%) 0.071
Parainfluenza 1 11 0 (0.00%) 11 (0.06%) >0.999
Parainfluenza 2 284 13 (0.89%) 271 (1.53%) 0.051
Parainfluenza 3 1,071 26 (1.77%) 1045 (5.89%) <0.001
Parainfluenza 4 210 7 (0.48%) 203 (1.14%) 0.018
Coronavirus 229E 51 2 (0.14%) 49 (0.28%) 0.434
Coronavirus HKU1 11 1 (0.07%) 10 (0.06%) 0.583
Coronavirus NL63 187 4 (0.27%) 183 (1.03%) 0.004
Coronavirus OC43 371 6 (0.41%) 365 (2.06%) <0.001
HMPV 1110 24 (1.64%) 1086 (6.12%) <0.001
Mycoplasma pneumoniae 2 0 (0.00%) 2 (0.01%) >0.999
Adenovirus 1277 62 (4.23%) 1215 (6.85%) <0.001
*

Chi-square or Fisher’s tests for independence between SARS-CoV-2 detection and detection of the other pathogen.

HMPV indicates human metapneumovirus; RSV, respiratory syncytial virus.